drugset / Trial / NCT01655927

Efficacy of Tranexamic Acid in Brain Tumor Resections

NCT01655927

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Tranexamic Acid is effective or not in the reduction of intraoperative bleeding loss in brain tumors resections.

Timeline

Start
2012-07
Primary completion
2013-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 mg/kg Intravenous